ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 101 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,630 | -11.7% | 803 | 0.0% | 0.00% | – |
Q2 2023 | $1,847 | -24.1% | 803 | 0.0% | 0.00% | – |
Q1 2023 | $2,433 | +108.8% | 803 | +60.6% | 0.00% | – |
Q4 2022 | $1,165 | +16.5% | 500 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 500 | -50.0% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -66.7% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $3,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 3,332,616 | $10,431,000 | 2.35% |
Think Investments LP | 2,000,000 | $6,260,000 | 1.16% |
RTW INVESTMENTS, LP | 5,978,355 | $18,712,000 | 0.45% |
COWEN AND COMPANY, LLC | 472,649 | $1,479,000 | 0.24% |
CADENCE CAPITAL MANAGEMENT LLC | 50,736 | $159,000 | 0.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 41,700 | $131,000 | 0.04% |
Hudson Bay Capital Management LP | 710,000 | $2,222,000 | 0.03% |
Ikarian Capital, LLC | 115,000 | $360,000 | 0.03% |
MIRABELLA FINANCIAL SERVICES LLP | 52,892 | $166,000 | 0.02% |
Secure Asset Management, LLC | 10,000 | $31,000 | 0.02% |